# Study of 203Pb-RMX-VH-PIB Dosimetry and Biodistribution in Patients With Glioblastoma Multiform (GBM) and Pancreatic Ductal Adenocarcinoma (PDAC)

> clinical trial · VERIFIED · 2026-08-07

Status: RECRUITING · Sponsor: Radiomedix, Inc. · Condition: Glioblastoma Multiforme (GBM)

- Company: Radiomedix, Inc.
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT07733674

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.